Elevance Health, Inc. reaffirmed its earnings guidance for 2025, expecting approximately $24.10 per diluted share, with an adjusted estimate of $30.00 per diluted share, reported on September 4, 2025. The company also anticipates a benefit expense ratio of around 90.0%.